Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation.

Herenius MM, Oliveira AS, Wijbrandts CA, Gerlag DM, Tak PP, Lebre MC.

PLoS One. 2013;8(2):e57802. doi: 10.1371/journal.pone.0057802. Epub 2013 Feb 27.


Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis.

Klaasen R, Herenius MM, Wijbrandts CA, de Jager W, van Tuyl LH, Nurmohamed MT, Prakken BJ, Gerlag DM, Tak PP.

Ann Rheum Dis. 2012 Sep;71(9):1510-6. doi: 10.1136/annrheumdis-2011-200646. Epub 2012 Mar 22.


Experiences and needs for work participation in employees with rheumatoid arthritis treated with anti-tumour necrosis factor therapy.

Van der Meer M, Hoving JL, Vermeulen MI, Herenius MM, Tak PP, Sluiter JK, Frings-Dresen MH.

Disabil Rehabil. 2011;33(25-26):2587-95. doi: 10.3109/09638288.2011.582923. Epub 2011 Jun 15.


Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab.

Herenius MM, Thurlings RM, Wijbrandts CA, Bennink RJ, Dohmen SE, Voermans C, Wouters D, Izmailova ES, Gerlag DM, van Eck-Smit BL, Tak PP.

Ann Rheum Dis. 2011 Jun;70(6):1160-2. doi: 10.1136/ard.2010.141549. Epub 2011 Feb 22.


Improvement of work ability, quality of life, and fatigue in patients with rheumatoid arthritis treated with adalimumab.

Herenius MM, Hoving JL, Sluiter JK, Raterman HG, Lems WF, Dijkmans BA, Tak PP, Nurmohamed MT, Voskuyl AE, Frings-Dresen MH.

J Occup Environ Med. 2010 Jun;52(6):618-21. doi: 10.1097/JOM.0b013e3181de8357.


Work ability: a new outcome measure in rheumatoid arthritis?

Raterman HG, Hoving JL, Nurmohamed MT, Herenius MM, Sluiter JK, Lems WF, Tak PP, Dijkmans BA, Twisk J, Frings-Dresen MH, Voskuyl AE.

Scand J Rheumatol. 2010 Mar;39(2):127-31. doi: 10.3109/03009740903447044.


Supplemental Content

Loading ...
Support Center